244 related articles for article (PubMed ID: 23043479)
21. The therapeutic potential of insulin-mimetic vanadium complexes.
Sakurai H; Yasui H; Adachi Y
Expert Opin Investig Drugs; 2003 Jul; 12(7):1189-203. PubMed ID: 12831353
[TBL] [Abstract][Full Text] [Related]
22. Increased potency of vanadium using organic ligands.
McNeill JH; Yuen VG; Dai S; Orvig C
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):175-80. PubMed ID: 8927036
[TBL] [Abstract][Full Text] [Related]
23. Antidiabetic, Chemical, and Physical Properties of Organic Vanadates as Presumed Transition-State Inhibitors for Phosphatases.
Crans DC
J Org Chem; 2015 Dec; 80(24):11899-915. PubMed ID: 26544762
[TBL] [Abstract][Full Text] [Related]
24. Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research.
Sekar N; Li J; Shechter Y
Crit Rev Biochem Mol Biol; 1996 Dec; 31(5-6):339-59. PubMed ID: 8994801
[TBL] [Abstract][Full Text] [Related]
25. Vanadium Compounds with Antidiabetic Potential.
Amaral LMPF; Moniz T; Silva AMN; Rangel M
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958659
[TBL] [Abstract][Full Text] [Related]
26. Is the hypoglycemic action of vanadium compounds related to the suppression of feeding?
Huang M; Wu Y; Wang N; Wang Z; Zhao P; Yang X
Biol Trace Elem Res; 2014 Mar; 157(3):242-8. PubMed ID: 24446192
[TBL] [Abstract][Full Text] [Related]
27. Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research.
Domingo JL; Gómez M
Food Chem Toxicol; 2016 Sep; 95():137-41. PubMed ID: 27417449
[TBL] [Abstract][Full Text] [Related]
28. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Yao J; Battell ML; McNeill JH
Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
[TBL] [Abstract][Full Text] [Related]
29. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
Xie M; Gao L; Li L; Liu W; Yan S
J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
[TBL] [Abstract][Full Text] [Related]
30. Vanadium (vanadyl sulfate). Monograph.
Altern Med Rev; 2009 Jun; 14(2):177-80. PubMed ID: 19594227
[No Abstract] [Full Text] [Related]
31. Biochemical and medical importance of vanadium compounds.
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Acta Biochim Pol; 2012; 59(2):195-200. PubMed ID: 22693688
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of vanadium compounds.
Djordjevic C
Met Ions Biol Syst; 1995; 31():595-616. PubMed ID: 8564819
[No Abstract] [Full Text] [Related]
33. Vanadium compounds as insulin mimics.
Orvig C; Thompson KH; Battell M; McNeill JH
Met Ions Biol Syst; 1995; 31():575-94. PubMed ID: 8564818
[TBL] [Abstract][Full Text] [Related]
34. [Vanadium derivatives--a new source of antidiabetic drugs].
Dănilă G; Lupaşcu D
Rev Med Chir Soc Med Nat Iasi; 1999; 103(3-4):74-7. PubMed ID: 10756929
[TBL] [Abstract][Full Text] [Related]
35. Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies.
Monga V; Thompson KH; Yuen VG; Sharma V; Patrick BO; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2678-88. PubMed ID: 15819553
[TBL] [Abstract][Full Text] [Related]
36. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.
Li M; Smee JJ; Ding W; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):585-9. PubMed ID: 19203797
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic potential of vanadium in treating diabetes mellitus].
Sakurai H
Clin Calcium; 2005 Jan; 15(1):49-57. PubMed ID: 15632473
[TBL] [Abstract][Full Text] [Related]
38. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
[TBL] [Abstract][Full Text] [Related]
39. In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds.
Rehder D; Costa Pessoa J; Geraldes CF; Castro MC; Kabanos T; Kiss T; Meier B; Micera G; Pettersson L; Rangel M; Salifoglou A; Turel I; Wang D
J Biol Inorg Chem; 2002 Apr; 7(4-5):384-96. PubMed ID: 11941496
[TBL] [Abstract][Full Text] [Related]
40. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]